In mouse models, CS3002 combined with PD-1 monoclonal antibody therapy
or endocrine therapy has shown improved tumor suppressing activities compared to monotherapies.
ENPNewswire-August 2, 2019--Queen Mary University of London: Promising antibody therapy
extends survival in mice with pancreatic cancer
This new patent builds upon NantKwest's extensive existing patent estate and broadens the company's established intellectual property combining haNK natural killer cell therapy together with antibody therapy
. This novel engineered haNK cell product represents the core foundational element of the Company's haNK therapeutics program.
Llamas, better known for its wool, have been used to produce a new antibody therapy
that has the potential to work against all types of flu, including new pandemics.
ISLAMABAD -- Hitting two targets on the cancer cell could greatly increase the power of antibody therapy
to kill ovarian cancer.
The study will test the subcutaneous bermekimab therapy in AD patients after only 4 or 8 weeks of treatment, compared with the 16 week treatment regimen currently used for the only approved antibody therapy
Bradley was treated with the antibody therapy
, among other treatments, during his first fight with the illness which started in 2013.
Merina Thomas, M.D., from the University of Michigan in Ann Arbor, and colleagues describe three patients who developed uveal effusion after initiation of anti-PD-1 and anti-PD-L1 monoclonal antibody therapy
. The patients were two white men aged 52 and 85 years with metastatic cutaneous melanoma and a 68-year-old African-American man with metastatic adenocarcinoma of the lung.
Nexvet's pipeline product ranevetmab, a mAb targeting nerve-growth factor for treatment of chronic pain associated with osteoarthritis in dogs, would, upon approval, be the companion animal industry's first monoclonal antibody therapy
administered monthly by injection for chronic pain.
Biopharmaceutical company Cantargia AB (STO: CANTA.ST) announced on Wednesday that the US Patent and Trademark Office (USPTO) has issued a Notice of Allowance on Its patent application regarding IL1RAP as a target molecule for antibody therapy
of acute lymphatic leukaemia (ALL).
Against the EGFR-targeted monoclonal antibody therapy
, when applied across all treatment lines either as a single agent or in combination with chemotherapy, the mutation could indicate the therapy's non-responsiveness.
Filings: XBiotech has been granted Fast Track Designation for its novel True Human monoclonal antibody therapy
intended to treat all forms of Staphylococcus aureus infections, including Methicillin-resistant S.